In addition to IgG4-related disease, rilzabrutinib has received orphan designations for immune thrombocytopenia (ITP) in the US, the EU, and Japan; and for warm autoimmune hemolytic anemia, IgG4-RD ...

Mumbai: Sanofi India has announced the appointment of Richa Bakshi as the People Excellence Lead (Senior Management Personnel ...

Four out of 10 eczema patients struggle with sleep, and they may not volunteer that information unless you ask.

Response Pharmaceuticals’ drug has helped reduce the amount of weight a patient regains after treatment with glucagon-like ...

Sanofi has initiated a Phase 2a clinical study titled A Parallel-group Treatment, Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Umbrella Study to Evaluate th ...

The outcome of this study could significantly impact Sanofi’s stock performance and investor sentiment, as successful results may enhance their competitive edge in the multiple sclerosis treatment ...

Families who have never shared their stories publicly before are speaking out following a series of special reports on ITV ...

OverviewIn 2025, data science offers lucrative roles across technology, finance, healthcare, and retail.Top careers include ...

With ongoing clinical trials and promising early data, tegoprubart may soon redefine the standard of care in transplantation ...

President Donald Trump has called on 17 pharmaceutical companies to implement most-favored-nation drug pricing in the next 60 days.

Novel Mechanism Demonstrates Clinically Meaningful Prevention of Weight Rebound and Metabolic Benefits After Stopping GLP-1 Therapy ...